Skip to main content
Fig. 1 | Biomarker Research

Fig. 1

From: Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1–2 follicular lymphoma: a real-world multicenter study

Fig. 1

Comparison of the cumulative incidence of the competing risks of relapse between FL1-2 and FL3a. A Cumulative incidence of the competing risk for relapse in patients with FL grade 1–2 or 3a. B-D Cumulative incidence of the competing risk for relapse in patients with FL grade 1–2 or 3a aged ≤ 40 years B, between 40 and 60 years C, and aged > 60 years D

Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us